Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-step synthesis of N,N-bis-[(R)-(2-methoxy-phenyl) cyanomethyl]-(S)-1-phenylethylamine using copper catalysis for high-purity pharmaceutical intermediates.
Novel patent CN106543146A offers efficient R-lansoprazole preparation. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical partners.
Patent CN108586528B details a cost-effective BINAP synthesis avoiding noble metals. Ideal for reliable pharma intermediate suppliers seeking scalable routes.
Novel chiral phosphine amide ester catalyst enables high enantioselectivity in Henry reactions, offering scalable solutions for pharmaceutical intermediates.
Patent CN110950793B details a metal-free, biphasic synthesis of chiral diarylindolemethanes with high stereoselectivity, offering cost-effective supply chain solutions.
Patent CN115677605A reveals a mild 5-step route for S-Fluralaner. Achieve higher ee values and yields with cost-effective chiral thiourea catalysis for veterinary markets.
Novel cyclic phosphine catalyst Le-Phos enables high-yield asymmetric gamma-addition. Efficient synthesis route reduces costs for API manufacturing.
Patent CN116514716A reveals a safer four-step synthesis route. This method offers significant supply chain stability and cost reduction benefits for global buyers.
Novel tetrameric zinc complexes enable high-yield Henry reactions. Reduces costs in pharmaceutical intermediate manufacturing via efficient catalysis.
Patent CN111620793A reveals a mild copper-catalyzed route for high-purity chiral nitriles. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable supply solutions.
Patent CN112110933A reveals a novel Pd-catalyzed route for high-purity lignan intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114478632B reveals high-ee chiral ligands for hydroformylation. Enhance supply chain reliability and reduce manufacturing costs with scalable synthesis.
Patent CN101570550A details a scalable, chromatography-free route for chiral ferrocene ligands, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN111454217A details a green Rh-catalyzed route for Avapritinib intermediates, offering safer chiral induction and scalable manufacturing for global supply chains.
Patent CN118406018A reveals a breakthrough chiral oxazoline ligand enabling efficient electrochemical dienylation with superior stereoselectivity and scalable manufacturing potential.
Patent CN110642843A details a novel Pd-catalyzed asymmetric [3+2] cyclization for chiral isonucleosides, offering high enantioselectivity and streamlined supply chains for API manufacturing.
Patent CN110642843A reveals a novel Pd-catalyzed asymmetric [3+2] cyclization for high-purity chiral isonucleosides, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN1940079A details a novel baker's yeast reduction for synthesizing (2S,3S)-2-benzoyl aminomethyl-3-hydroxy-butyrate, a critical 4-AA precursor, offering mild conditions and high optical purity.
Novel bisaryl substituted catalyst enables high stereoselectivity. Reduces manufacturing costs and ensures supply chain reliability for complex pharmaceutical intermediate production.
Patent CN105085189A details a robust aprotic solvent method for chiral alcohol synthesis, offering significant supply chain stability and cost reduction for pharmaceutical intermediates.